About: Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on September 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована у вересні 2009 (uk) مقالة علمية نشرت في سبتمبر 2009 (ar) scientific article published on September 2009 (en)
publication date	wds:Q37363328-74D24136-ABB8-4B6F-8E66-9080239B835D
publication date	2009-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37363328-42DE4891-598A-42C8-8439-F9A9CBAAEA3A
language of work or name	English
exact match	wds:Q37363328-7C97567C-5A6D-4633-9E20-86B85254F46A
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605271
cites work	wds:Q37363328-082B8CB6-39C4-4441-9118-29C75F0F578A wds:Q37363328-41F3F784-CFA8-4809-98A8-CAAB8562F2AF wds:Q37363328-5489A6B8-E840-432C-A533-B44ADE456965 wds:Q37363328-694313B6-44D8-4BA9-A52D-C3C7008F2A3E wds:Q37363328-87816AC4-B27C-4DB6-9FF3-62AD29C8EBC2 wds:Q37363328-A9E26557-7C63-462A-B701-83F7B23E25F1 wds:Q37363328-C40C44BA-8FAF-4796-ADDF-B2C591621B08 wds:Q37363328-C993ACEC-55D4-4A84-8C9E-4A26F7FCFB2F wds:Q37363328-ED48C8C1-DA2C-449B-BE3D-F4573BC298BB wds:Q37363328-FC898DD3-7A9E-4C81-A32B-5392ABA3EA8A
cites work	2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors Prevention of febrile neutropenia: use of prophylactic antibiotics Myeloid growth factors
author name string	wds:Q37363328-D9E61C8A-6B41-4621-BE93-94F81AC65813
author name string	P Trueman
rdfs:label	Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (en) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (nl) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (ast)
skos:prefLabel	Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (en) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (nl) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (ast)
name	Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (en) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (nl) Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (ast)
title	wds:Q37363328-DF003330-9467-4ADA-9600-CF0731921E70
title	Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review (en)
page(s)	wds:Q37363328-977B7641-3F00-40F1-8B8A-F4AAF106D3E1
page(s)	S15-7
instance of	wds:Q37363328-68552AD9-A9D9-4DC9-8F3F-36126A2E168D
instance of	scholarly article
main subject	wds:Q37363328-51617D19-6312-4D94-ADFA-DD71EA01CE77
main subject	breast cancer
PubMed ID	wds:Q37363328-278EEF46-DA02-421D-8817-EC686344690D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19756001
PubMed ID	19756001
published in	wds:Q37363328-1877DCE8-58C8-45A9-A6B2-9351A2ABB3CF
published in	British Journal of Cancer
volume	wds:Q37363328-B3B204C1-B888-4FD3-9A58-36E682F69951
volume	101 Suppl 1
DOI	wds:Q37363328-55DEB0E4-7C51-4F79-B86E-BC83F5940EB8
DOI	http://dx.doi.org/10.1038/SJ.BJC.6605271
DOI	10.1038/SJ.BJC.6605271
ResearchGate publication ID	wds:Q37363328-83D0A8F8-4494-4E23-8699-B83ECAD35F22
ResearchGate publication ID	26813815
Dimensions Publication ID	wds:Q37363328-74F29E24-599C-491A-9112-4A9BDF287E8B
Dimensions Publication ID	1000313709
PMCID	wds:Q37363328-C4113D1B-E6F0-47E8-BA73-BC48F4C3C936
PMCID	2752222
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37363328
is cites work of	Costs associated with febrile neutropenia in the US. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review. Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: c Leptin-cytokine crosstalk in breast cancer. Impact of effective prevention and management of febrile neutropenia Prevention of febrile neutropenia: use of prophylactic antibiotics A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer
is cites work of	wds:Q40274712-69C5D7A6-E777-4405-9DCF-73685295707F wds:Q33503548-886B2624-22C2-44B7-81F4-0956DB732E80 wds:Q40280346-353FA91E-DB38-45E7-A392-646CCA67CFFB wds:Q37351155-930A3822-E70F-4A67-8FF9-5870F3EC4603 wds:Q38940016-4942F7FB-F132-474E-B848-8B4DFB0AAA32 wds:Q35584817-E6DA1929-8E8A-4212-A35F-CA1A9506116B wds:Q24198118-B441C9B4-32D2-4785-A2EC-2090330177FB wds:Q37363337-8043A418-F1F2-476B-969C-72D9578C3BFD

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software